Our Mission

Provide a professional counseling and guidance system to those diagnosed with Diabetes, with the ultimate objective of restoring the patient's normal endocrine functions, eliminating the need for future pharmacologic intervention and providing a higher quality of life for participants.

About us

We are assembling our executive team to expand our Specialists program to legions of others suffering from this disease. The founding members of this team have spent their lives providing quality health care in the United States and abroad. They have seen and treated the effects of diabetes, and the related suffering taking place in the lives of those so afflicted and their families.

Our Work

The objective of the U.K. Prospective Diabetes Study (UKPDS), initiated in 1977, was set up to determine whether improved blood glucose control in people with type 2 diabetes will prevent complications of diabetes. The UKPDS was also designed to determine whether there are differences between conventional policy (diet therapy) and three different regimens of intensive treatment policy, based on sulfonylurea, metformin, or insulin. Interim efficacy analyses revealed that the intensive policies with sulfonylurea, insulin and metformin were equally effective in reducing fasting plasma glucose concentrations. However, glucose and HbA1c (A1C) measurements steadily increased with time, reflecting ongoing deterioration of beta cell function. Cardiovascular disease was the major cause of complications, and the risk factors included raised LDL cholesterol concentrations, low HDL cholesterol complications, elevated blood pressure, elevated A1C concentrations, and smoking. A final study report was issued in September 1998, when the median duration of therapy was 11 years.